Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...
Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...
Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
Moderna’s stock was surging after the FDA said it would review the biotech’s flu-vaccine candidate, a week after it had ...
The decision follows a pattern of policy shifts, including the rollback of COVID-19 recommendations and cancellation of mRNA funding.
Trump’s health secretary has halted federal flu vaccine promotions, citing personal beliefs about vaccine risks.
As Illinois experiences its most severe flu season in over a decade, public health officials report rising hospitalizations and lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results